Doxazosin Tablet
Product Images NDC 71335-0309

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 71335-0309). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Table 1 (Doxazosin Fig1)

Table 1 (Doxazosin Fig1)
FDA Label Image

Figure 1 – Study 1 (Doxazosin Fig2)

Figure 1 – Study 1 (Doxazosin Fig2)
The text provides a table of Mean Increase in Maximum Urinary Flow Rate and Mean Change in Total Symptom Score compared to Placebo and Baseline after a certain duration of treatment (in weeks). It also mentions the use of Doxazosin Titration up to a maximum of 8 mg.*
FDA Label Image

Chemical Structure (Doxazosin Str)

Chemical Structure (Doxazosin Str)
FDA Label Image

Label Image (Lbl713350309)

Label Image (Lbl713350309)
This is a medication package of Doxazosin Mesylate tablets with a strength of 2mg. The tablets are round and yellow with an imprint of "C7". The package contains 30 tablets and was prepacked by Bryant Ranck Prepack Bunbauk. The tablets should be stored at room temperature and kept out of reach of children. The NDC number for the medication is 7133503091 and the expiration date is not specified.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.